Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04537052
Other study ID # 11-2020/01
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 27, 2020
Est. completion date January 30, 2021

Study information

Verified date September 2020
Source Kahramanmaras Sutcu Imam University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To present the 9. months clinical results of percutaneous Ven Restoration Therapy (VRT), a new method in the treatment of primary femoral vein insufficiency.Twenty four patients diagnosed with isolated primary femoral vein insufficiency between January 2020 and December 2020 were included in the study. Before the procedure, junctional femoral vein diameters and reflux times were measured. CEAP classification and Venous clinical severity scores (VCSS) were recorded. Chronic Venous Insufficiency Questionnaire (CIVIQ-20) were also recorded. Then, VRT was applied percutaneously to the anterior and posterior of the femoral veins of the patients, and the diameter of the femoral vein was narrowed and valve coaptation was achieved. After the procedure, vein diameters and reflux times were measured again. All parameters were reevaluated by calling patients for control at 1.,3., 6. and 9. months.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 24
Est. completion date January 30, 2021
Est. primary completion date December 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Patients with isolated deep venous insufficiency, without accompanying superficial venous insufficiency,

- volunteering to take part in the study were included

Exclusion Criteria:

- post-thrombotic or congenital deep venous insufficiency

- Venous reflux disease in the GSV diagnosed by clinical symptoms

- Local or systemic infection

Study Design


Intervention

Procedure:
Ven Restoration Therapy
This is a novel and promising method, applied percutaneously, in the treatment of deep venous insufficiency . In this method, developed based on the effects of compression garments, a polymer consisting of cyanoacrylate and hyaluronic acid is injected, with ultrasound-guidance, percutaneously around the femoral vein. In this way, the diameter of the vein is reduced, and function is restored to the inadequately functioning valve. The procedure is also called percutaneous valvuloplasty. The underlying idea in the development of this product was that hyaluronic acid might cause an increase in connective tissue, while cyanoacrylate could serve as an exoskeleton by forming heavy tissue.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Kahramanmaras Sutcu Imam University

Outcome

Type Measure Description Time frame Safety issue
Primary femoral vein diameters reduce femoral vein diameter 9 months
Primary reflux times reduce reflux times 9 months